The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel modes of action are urgently needed.

Antibiotic resistance is a growing problem, and it’s one that large pharmaceutical companies have largely abandoned. Some startups are filling the gap, and a new one, ArrePath, has novel molecules ...